University of Texas MD Anderson Cancer Center

1200px-MD_Anderson_Cancer_Center_logo5rt

The University of Texas MD Anderson Cancer Center (colloquially MD Anderson Cancer Center) is a comprehensive cancer center in Houston, Texas

Using whole blood exchange to help with Alzheimer’s disease?

Could PUL-042, an inhaled therapeutic, be directed against all existing and future variants of the COVID-19 virus as well as future pandemics?

COVID-19 Nasal Vaccine Candidate Effective at Preventing Disease Transmission

Could a polymer wafer placed under the tongue deliver vaccines?

Can activation of a distinct genetic pathway slow the progress of metastatic breast cancer?

‘Quadrapeutics’ works in preclinical study of hard-to-treat tumors

The first preclinical study of a new Rice University-developed anti-cancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells — often by blowing them apart — without harming surrounding normal organs. The research, which is available online this week Nature Medicine, reports that Rice’s “quadrapeutics” technology

‘Quadrapeutics’ works in preclinical study of hard-to-treat tumors

OHSU researchers develop new drug approach that could lead to cures for wide range of diseases

A team led by a longtime Oregon Health & Science University researcher has demonstrated in mice what could be a revolutionary new technique to cure a wide range of human diseases — from cystic fibrosis to cataracts to Alzheimer’s disease — that are caused by “misfolded” protein molecules. Misfolded protein molecules, caused by gene mutation,

OHSU researchers develop new drug approach that could lead to cures for wide range of diseases

New Screening Strategy May Catch Ovarian Cancer at Early Stages

A new screening strategy for ovarian cancer appears to be highly specific for detecting the disease before it becomes lethal. The strategy is described in a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. If verified in an ongoing clinical trial, it could potentially help save the lives of

New Screening Strategy May Catch Ovarian Cancer at Early Stages

‘Nanobubbles’ Plus Chemotherapy Equals Single-Cell Cancer Targeting

Up to 30 times more deadly to cancer cells Using light-harvesting nanoparticles to convert laser energy into “plasmonic nanobubbles,” researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells. In tests on drug-resistant

‘Nanobubbles’ Plus Chemotherapy Equals Single-Cell Cancer Targeting

‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells

High-density lipoprotein’s hauls excess cholesterol to the liver for disposal, but new research suggests “good cholesterol” can also act as a special delivery vehicle of destruction for cancer. Synthetic HDL nanoparticles loaded with small interfering RNA to silence cancer-promoting genes selectively shrunk or destroyed ovarian cancer tumors in mice, a research team led by scientists

‘Good Cholesterol’ Nanoparticles Seek and Destroy Cancer Cells

The Latest Bing News on:

University of Texas MD Anderson Cancer Center Research

MD Anderson and Advanced Biology collaborate to host the virtual Cancer Neuroscience Symposium
The University of Texas MD Anderson Cancer Center will host the virtual Cancer Neuroscience Symposium Sept. 22-23, 2022, in collaboration with the journal Advanced Biology.
Science Reveals That This Type of Diet Can Increase Your Risk of Pancreatic Cancer
According to a new study, substances that are said to boost athletic performance can also activate a receptor that speeds up the development of pancreatic cancer in mice. The progression of precancero ...
New Leukemia-Killing Compounds Discovered
New study highlights potential of mitochondria-targeted chemotherapies. Scientists have discovered promising new drugs that work in concert with other drugs to deliver a deadly one-two punch to ...
MD Anderson appoints division head of pathology and laboratory medicine
Donna Hansel, MD, PhD, has been named division head of pathology and laboratory medicine at The University of Texas MD Anderson Cancer Center.Hansel’s appointment will take effect Sept. 12.
MD Anderson named #1 in the nation for cancer care
The institution has been one of the nation’s top two hospitals for cancer care since the survey’s inception in 1990 ...

The Latest Google Headlines on:

University of Texas MD Anderson Cancer Center Research

MD Anderson named #1 in the nation for cancer care - MD Anderson
July 26, 2022
MD Anderson Research Highlights for July 27, 2022 - Newswise
July 27, 2022
MD Anderson and Obsidian Therapeutics announce FDA Clearance of IND application for novel TIL therapy OBX-115 - PR Newswire
July 21, 2022
MD Anderson appoints division head of pathology and laboratory medicine - Healio
July 24, 2022
Donna Hansel, M.D., Ph.D., to join MD Anderson as Division Head of Pathology and Laboratory Medicine - Newswise
July 13, 2022

The Latest Bing News on:

University of Texas MD Anderson Cancer Center Discovery

MD Anderson again ranked best cancer hospital in US
The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.MD Anderson tops U.S. News & World Report’s 2022-2023 Best Hospitals rankings ...
New Leukemia-Killing Compounds Discovered
New study highlights potential of mitochondria-targeted chemotherapies. Scientists have discovered promising new drugs that work in concert with other drugs to deliver a deadly one-two punch to ...
MD Anderson appoints division head of pathology and laboratory medicine
Donna Hansel, MD, PhD, has been named division head of pathology and laboratory medicine at The University of Texas MD Anderson Cancer Center.Hansel’s appointment will take effect Sept. 12.
Biopharma has a brand new target: Cancer-specific collagen
Researchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen to help them grown and proliferate. This means ...
MD Anderson, Obsidian get US FDA clearance to begin phase I study of novel TIL therapy, OBX-115 to treat solid tumours
MD Anderson, Obsidian get US FDA clearance to begin phase I study of novel TIL therapy, OBX-115 to treat solid tumours: Houston, Texas Friday, July 22, 2022, 18:00 Hrs [IST] The U ...